Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
International Angiology : a Journal of the International Union of Angiology|April 10, 2002
Exclusion and diagnosis of deep vein thrombosis in outpatients by sequential noninvasive toolsJ J Michiels, H Kasbergen, R Oudega, et al.Acta Chirurgica Belgica|March 26, 2005
Diagnosis of deep vein thrombosis: how many tests do we need?J J Michiels, A Gadisseur, M van der Planken, et al.International Angiology : a Journal of the International Union of Angiology|May 7, 2005
A critical appraisal of non-invasive diagnosis and exclusion of deep vein thrombosis and pulmonary embolism in outpatients with suspected deep vein thrombosis or pulmonary embolism: how many tests do we need?J J Michiels, A Gadisseur, M Van Der Planken, et al.Tropical Medicine & International Health : TM & IH|September 15, 1998
Recurrence of blackwater fever: triggering of relapses by different antimalarialsJ Van den Ende, G Coppens, T Verstraeten, et al.Bone Marrow Transplantation|December 11, 2012
Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study from the European Group for Blood and Marrow TransplantationS Cesaro, M Pillon, G Tridello, et al.Blood|August 10, 1999
Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirements in multiple myeloma patients: a randomized, controlled trialT Facon, J L Harousseau, F Maloisel, et al.Bone Marrow Transplantation|December 1, 2015
Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working PartyS P Robinson, A Boumendil, H Finel, et al.Bone Marrow Transplantation|September 22, 2019
Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)E González-Barca, A Boumendil, D Blaise, et al.Pageof 4